BioCopy

Info

We invented the biomolecule copier. With its help we want to revolutionize the way vaccine precursors are discovered.

"BioCopy is a multinational company headquartered in Switzerland with a state-of-the-art research and development facility in Germany. We focus on immuno-oncology drug development using our unique platform technology based on extensive expertise in microarray customization, binding kinetics and bioinformatics. BioCopy's experts are continuously working on improving the proprie-tary screening technology for the characterization and validation of immune responses of TCR-based immuno-oncology drug candidates, such as TCRms."